ABCB1 and breast cancer: MiR-34b-5p overexpression or ABCB1 silencing enhanced the sensitivity of bladder carcinoma (BC) cells to cisplatin by inhibiting cell viability and facilitating cell apoptosis in cisplatin-exposed BC cells [31].